期刊
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
卷 47, 期 5, 页码 429-437出版社
ELSEVIER TAIWAN
DOI: 10.1016/j.jmii.2013.03.010
关键词
Eradication treatment; Gastritis; Helicobacter pylori; Interleukin-6; Lactobacillus; Stomach cancer
The role of probiotics in the treatment of gastrointestinal infections is increasingly being documented as an alternative or complement to antibiotics, with the potential to decrease the use of antibiotics or reduce their side effects. Although antibiotics-based Helicobacter pylori eradication treatment is 90% effective, it is expensive and causes antibiotic resistance associated with other adverse effects. Probiotics have an in vitro inhibitory effect on H. pylori. Animal studies demonstrated that probiotic treatment is effective in reducing H. pylori-associated gastric inflammation. About 12 human studies investigated the efficacy of combinations of antibiotics and probiotics, whereas 16 studies used probiotic alone as an alternative to antibiotics for the treatment of H. pylon infection. Most of the studies showed an improvement of H. pylon gastritis and decrease in H. pylon colonization after administration of probiotics. However, no study could demonstrate complete eradication of H. pylori infection by probiotic treatment. Probiotic combinations can reduce adverse effects induced by H. pylori eradication treatment and, thus, have beneficial effects in H. pylori-infected individuals. Long-term intakes of products containing probiotic strains may have a favorable effect on H. pylon infection in humans, particularly by reducing the risk of developing disorders associated with high degrees of gastric inflammation. Copyright (C) 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据